Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities
Cancers · 21.03.2024 · 16 (6) · 1235
DOI: 10.3390/cancers16061235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 21.03.2024. Verfasst von Tae Hoon Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to present the treatment patterns and outcomes for adenoid cystic carcinoma (ACC) arising in the nasal cavity and paranasal sinus. Sixty-one sinonasal ACC patients were retrospectively reviewed: 31 (50.8%) underwent surgery followed by postoperative radiation therapy (S+PORT), and 30 (49.2%) received definitive radiation therapy (D(C)RT). T4 disease was significantly more frequent in the D(C)RT group (25.8% vs. 80.0%, p < 0.001), where all T4b disease patients underwent D(C)RT. The 5-year local failure-free survival (LFFS), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival were 61.8% versus 37.8% (p = 0.003), 64.8% versus 38.1% (p = 0.036), 52.6% versus 19.3% (p = 0.010), and 93.2% versus 73.4% (p = 0.001) in the S+PORT and D(C)RT groups, respectively. The absolute differences in 5-year rates of LFFS, DMFS, and PFS between the two groups were smaller in the T3–4 subgroup. The univariate analysis showed that T4b disease, neurologic symptoms, longest diameter of tumor, radiological evidence of nerve involvement, and undergoing D(C)RT were associated with worse clinical outcomes, but the significance disappeared in the multivariate analysis, except for in the case of radiological evidence of nerve involvement. In conclusion, most patients with extensive disease underwent upfront D(C)RT and generally exhibited inferior clinical outcomes when compared to those with less extensive disease and who underwent S+PORT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
- Department of Radiation Oncology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju 63241, Republic of Korea.
- Department of Otorhinolaryngology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
ORCID-Profile: Tae Hoon Lee, Dongryul Oh, Kyungmi Yang, Man Ki Chung, Yong Chan Ahn
Zitieren
APA
Lee, T. H., Kim, K., Oh, D., Yang, K., Jeong, H. S., Chung, M. K., & Ahn, Y. C. (2024). Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities. Cancers, 16(6), 1235. https://doi.org/10.3390/cancers16061235
Vancouver
Lee TH, Kim K, Oh D, Yang K, Jeong HS, Chung MK, et al. Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities. Cancers. 2024;16(6):1235. doi:10.3390/cancers16061235
BibTeX
@article{Lee2024,
author = {Lee, Tae Hoon and Kim, Kangpyo and Oh, Dongryul and Yang, Kyungmi and Jeong, Han-Sin and Chung, Man Ki and Ahn, Yong Chan},
title = {Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities},
journal = {Cancers},
year = {2024},
volume = {16},
number = {6},
pages = {1235},
doi = {10.3390/cancers16061235}
}
EUVIMED